Search results
2 new COVID variants called 'FLiRT' are spreading in the U.S. What are the symptoms?
TODAY via Yahoo News· 2 days agoThe new "FLiRT" COVID-19 variants, including KP.2, are spreading in the United States. Will there be...
New COVID-19 FLiRT variants are now the dominant variant. Could there be a summer surge?
USA TODAY via Yahoo News· 18 hours agoSymptoms may appear two to 14 days after exposure. Latest COVID guidance from the CDC In March 2024, the CDC updated its COVID-19 guidance ...
Will your last COVID vaccine work against new ‘FLiRT’ variants?
WJZY via Yahoo News· 4 days ago(NEXSTAR) — There are two new COVID-19 variants circulating, posing a threat to a summer surge. The...
Earnings call: Atea Pharmaceuticals reports progress in COVID-19 trial
Investing.com· 1 day agoThe company reported the completion of patient enrollment ahead of schedule for its SUNRISE-3 global...
If You'd Invested $1,000 in Moderna Stock 5 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 7 days agoBut the science of DNA-based drugs was on the experimental fringe of the biopharma landscape. Not...
Which Former U.S. Presidents Are Still Alive? What the Remaining 5 Have Been Up to Since Leaving...
People via Yahoo News· 13 hours ago"Former U.S. President Jimmy Carter today decided to spend his remaining time at home with his...
Q1 2024 Predictive Oncology Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 hours agoM2SR also has shown activity as a vaccine vector for other respiratory vaccines and infectious diseases, including a COVID-19 Flu combination. With our ...
A tale of two nurses: How average travel nurse compensation compares to all US nurse salaries
Stacker via AOL· 1 day agoShutterstock // Gorodenkoff Heightened demand made nursing a high-paying profession over the last...
What’s driving the anti-vax movement? | The Excerpt
USA Today· 4 days agoCORRECTION: This episode has been updated to remove an incorrect reference to the HPV vaccine. On Sunday’s episode of The Excerpt podcast: Whether...
Earnings call: GeoVax reports progress on key vaccine trials By Investing.com
Investing.com· 16 hours agoCEO David Dodd discussed significant advancements in the company's Phase 2 clinical trials,...